Felipe Couñago, National Clinical Director of GenesisCare Spain, shared a recent article on X:
“First RAPID-RT analysis at ESTRO25: real-world data and rapid-learning show promising survival benefit with cardiac avoidance in lung RT. A scalable path to refine practice when RCTs aren’t feasible. Smart science, smarter care.”
More posts featuring ESTRO.